[PSS21] Cost-Effectiveness of A 0.2 mg/Day Fluocinolone Acetonide (FAC) Implant In The Treatment Chronic Diabetic Macular Oedema (DMO) In The UK
HomePublications[PSS21] Cost-Effectiveness of A 0.2 mg/Day Fluocinolone Acetonide (FAC) Implant In The Treatment Chronic Diabetic Macular Oedema (DMO) In The UK